Stay updated on NRX100 vs. Placebo in Suicidal Bipolar Depression Clinical Trial
Sign up to get notified when there's something new on the NRX100 vs. Placebo in Suicidal Bipolar Depression Clinical Trial page.

Latest updates to the NRX100 vs. Placebo in Suicidal Bipolar Depression Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.5.2 was added to the version history, and the previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 on the Record History page.SummaryDifference0.1%

- Check37 days agoChange DetectedThe record history now shows a new revision entry v3.4.3 and the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded Revision: v3.4.2 to the record history. Removed the government-funding lapse notice and the earlier Revision: v3.4.1.SummaryDifference0.8%

- Check73 days agoChange DetectedRecord History now shows a new version (v3.4.1) with an updated last known status (Unknown) for NeuroRx, Inc. A system-wide notice about government funding is also displayed, and the previous revision (v3.4.0) was removed.SummaryDifference1%

- Check80 days agoChange DetectedThe updates are minor UI and labeling changes to the study history page, including a glossary toggle, color-coded legends for additions and deletions, and the Revision: v3.4.0 label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

Stay in the know with updates to NRX100 vs. Placebo in Suicidal Bipolar Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NRX100 vs. Placebo in Suicidal Bipolar Depression Clinical Trial page.